Skip to main content
Caplight Logo









NYBC Ventures

NYBC Ventures

Boston, Massachusettsnybcventures.com

Overview

NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies, and related technologies. The fund invests in therapeutics, devices, and cutting-edge technologies that address critical challenges in these fields. Its mission is to improve patient outcomes by supporting groundbreaking therapeutics, platforms, and collaborative efforts.

Year Founded

2022

Portfolio Companies

13

Investments

NYBC Ventures investments
CompanyDateStageLead
City TherapeuticsJun 2026Series BCo-investor
VitestroMar 2026Series BCo-investor
Cellular OriginsDec 2025Series ACo-investor
Akadeum Life SciencesJun 2025VC RoundCo-investor
Vittoria BiotherapeuticsNov 2024Private Financing ExtensionCo-investor

Key People

Meg Wood

Managing Director

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?